PAH-DNA adducts, cigarette smoking, GST polymorphisms, and breast cancer risk

Environmental Health Perspectives

Volumn 117, Issue 4, 2009, Pages 552-558

  McCarty, Kathleen M ^a,b   Santella, Regina M ^c   Steck, Susan E ^d   Cleveland, Rebecca J ^a   Ahn, Jiyoung ^e   Ambrosone, Christine B ^f   North, Kari ^a   Sagiv, Sharon K ^a   Eng, Sybil M ^g   Teitelbaum, Susan L ^h   Neugut, Alfred I ^c,i   Gammon, Marilie D ^a  

^a IL   (United States)

^b YALE UNIVERSITY   (United States)

^c Columbia University ^*  (United States)

^d UNIVERSITY OF SOUTH CAROLINA   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f ROSWELL PARK CANCER INSTITUTE   (United States)

^g PFIZER INC   (United States)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

ⁱ NONE   (United States)

Author keywords

Breast cancer; GST; Long island; PAH DNA adducts; Smoking

Indexed keywords

GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE A1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CARCINOGEN DNA INTERACTION; CIGARETTE SMOKING; CONTROLLED STUDY; DNA ADDUCT; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME POLYMORPHISM; FEMALE; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING HABIT;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DNA ADDUCTS; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; MIDDLE AGED; POLYCYCLIC HYDROCARBONS, AROMATIC; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS; SMOKING;

EID: 64049115182     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.0800119     Document Type: Article

References (65)

1. Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, et al. 2006. Effects of glutathione S-transferase A1 (GSTA1) genotype and potential modifiers on breast cancer risk. Carcinogenesis 9:1876-1882.
2. Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, et al. 1995. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res 55(16):3483-3485.
3. Assmann SF, Hosmer DW, Lemeshow S, Mundt KA. 1996. Confidence intervals for measures of interaction. Epidemiology 7(3):286-290.
4. Bell DA, Thompson CL, Taylor J, Miller CR, Perera F, Hsieh LL, et al. 1992. Genetic monitoring of human polymorphic cancer susceptibility genes by polymerase chain reaction: application to glutathione transferase mu. Environ Health Perspect 98:113-117.
5. Boffetta P, Jourenkova N, Gustavsson P. 1997. Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control 8:444-472.
6. Brescia G, Celotti L, Clonfero E, Neumann GH, Forni A, Foa V, et al. 2004. The influence of cytochrome P450 1A1 and glutathione S-transferase M1 genotypes on biomarker levels in coke-oven workers. Arch Toxicol 73:431-439.
7. Butkiewicz D, Grzybowska E, Phillips DH, Hemminki K, Chorazy M. 2000. Polymorphisms of the GSTP1 and GSTM1 genes and PAH-DNA adducts in human mononuclear white blood cells. Environ Mol Mutagen 35(2):99-105
8. Cavalieri EL, Higginbotham S, RamaKrishna KNVS, Devanesan PD, Todorovic R, Rogan EG, et al. 1991. Comparative dose-response tumorigenicity studies of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene, benzo[a]pyrene and two dibenzo[a,l]pyrene dihydrodiols in mouse skin and rat mammary gland. Carcinogenesis 10:1939-1944.
9. Coles B, Nowell SA, MacLeod SL, Sweeny C, Lang NP, Kadlubar FF. 2001b. The role of human glutathione S-transferases (hGSTs) in the detoxification of food-derived carcinogen metabolite N-acetoxy-PhIP, and the effect of a polymorphism in hGSTA1 on colorectal cancer risk. Mutat Res 482:3-10.
10. Coles BF, Kadlubar FF. 2003. Detoxification of electrophilic compounds by glutathione S-transferase catalysis: determinants of individual response to chemical carcinogens and chemotherapeutic drugs? Biofactors 17:115-130.
11. Coles BF, Kadlubar FF, Sies H, Packer L. 2005. Human alpha class glutathione S-transferases: genetic polymorphism, expression, and susceptibility to disease. Methods Enzymol 401:9-42.
12. Coles BF, Morel F, Rauch C, Huber WW, Yang M, Teitel CH, et al. 2001a. Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression. Pharmacogenetics 11:663-669.
13. el-Bayoumy K, Chae YH, Upadhyaya P, Rivenson A, Kurtzke C, Reddy B, Hecht SS. 1995. Comparative tumorigenicity of benzo[a]pyrene, 1-nitropyrene and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine administered by gavage to female CD rats. Carcinogenesis 16:431-434.
14. Fannon WR. 2002. Single nucleotide polymorphism (SNP) analysis of a variety of non-ideal DNA sample types by SEQUENOM MassARRAY matrix assisted laser desorption/ionization time of flight (MALDI-TOF). Proc Am Assoc Cancer Res 43:53.
15. Fields WR, Morrow CS, Doss AJ, Sundberg K, Jernström B, Townsend AJ. 1998. Overexpression of stably transfected human glutathione S-transferase P1-1 protects against DNA damage by benzo[a]pyrene diol-epoxide in human T47D cells. Mol Pharmacol 54(2):298-304.
16. Gammon MD, Eng SM, Teitelbaum SL, Britton JA, Kabat GC, Hatch M, et al. 2004a. Environmental tobacco smoke and breast cancer incidence. Environ Res 96(2):176-185.
17. Gammon MD, Neugut AI, Santella RM, Teitelbaum SL, Britton JA, Terry MB, et al. 2002a. The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res Treat 74:235-254.
18. Gammon MD, Sagiv SK, Eng SM, Shantakumar S, Gaudet MM, Teitelbaum SL, et al. 2004b. Polycyclic aromatic hydrocarbon-DNA adducts and breast cancer: a pooled analysis. Arch Environ Health 59:640-649.
19. Gammon MD, Santella RM. 2008. PAH, genetic susceptibility, and breast cancer risk: an update from the Long Island Breast Cancer Study Project. Eur J Cancer 44(5):636-640.
20. Gammon MD, Santella RM, Neugut AI, Eng SM, Teitelbaum SL, Paykin A, et al. 2002b. Environmental Toxins and Breast Cancer on Long Island I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiol Biomarkers Prev 11:677-685.
21. García-Closas M, Kelsey KT, Hankinson SE, Spiegelman D, Springer K, Willett WC, et al. 1999. Glutathione S-transferase mu and theta polymorphisms and breast cancer susceptibility. J Natl Cancer Inst 91(22):1960-1964.
22. Garte S, Taioli E, Popov T, Kalina I, Sram R, Farmer P. 2007. Role of GSTT1 deletion in DNA oxidative damage by exposure to polycyclic aromatic hydrocarbons in humans. Int J Cancer 120(11):2499-2503.
23. Grinberg-Funes RA, Singh VN, Perera FP, Bell DA, Young TL, Dickey C, et al. 1994. Polycyclic aromatic hydrocarbon-DNA adducts in smokers and their relationship to micronutrient levels and the glutathione-S-transferase M1 genotype. Carcinogenesis 15(11):2449-2454.
24. Hatsukami DK, Benowitz N, Rennard S, Oncken C, Hecht SS. 2006. Biomarkers to assess the utility of potential reduced exposure tobacco products. Nicotine Tob Res 8:599-622.
25. Hayes JD, Pulford DJ. 1995. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30:445-600.
26. Hecht SS. 1996. Chemoprevention of lung cancer by isothiocyanates. Adv Exp Med Biol 401:1-11.
27. Hecht SS. 1999. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91(14):1194-1210.
28. Hecht SS. 2000. Inhibition of carcinogenesis by isothiocyanates. Drug Metab Rev 32(3-4):395-411.
29. Hecht SS. 2003. Tobacco carcinogens, their biomarkers, and tobacco induced cancer. Nature Rev Cancer 3:733-744.
30. Hecht SS, Carmella SG, Yoder A, Chen M, Li Z, Le C, et al. 2006. Comparison of polymorphisms in genes involved in polycyclic aromatic hydrocarbon metabolism with urinary phenanthrene metabolite ratios in smokers. Cancer Epidemiol Biomarker Prev 15:1805-1811.
31. Helzlsouer KJ, Selmin O, Huang HY, Strickland PT, Hoffman S, Alberg AJ, et al. 1998. Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J Natl Cancer Inst 90(7):512-518.
32. Hosmer DW, Lemeshow S. 1989. Applied Logistic Regression. New York:John Wiley and Sons.
33. Hu Y, Li G, Xue X, Zhou Z, Li X, Fu J, et al. 2007. PAH-DNA adducts in a Chinese population: relationship to PAH exposure, smoking, and polymorphisms of metabolic and DNA repair genes. Biomarkers 13(1):27-40.
34. Korashy H, El-Kadi A. 2006. The role of aryl hydrocarbon receptor in the pathogenesis of cardiovascular diseases. Drug Metab Rev 38:411-450.
35. Kuljukka-Rabb T, Nylund L, Vaaranrinta R, Savela K, Mutanene P, Veidebaum T, et al. 2002. The effect of relevant genotypes on PAH exposure-related biomarkers. J Expo Anal Environ Epidemiol 12:89-91.
36. Li D, Walcott FL, Chang P, Zhang W, Zhu J, Petrulis E, et al. 2002. Genetic and environmental determinants on tissue response to in vitro carcinogen exposure and risk of breast cancer. Cancer Res 62:4566-4570.
37. Li D, Wang M, Dhingra K, Hittelman WN. 1996. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res 56:287-293.
38. Lioy PJ, Greenberg A. 1990. Factors associated with human exposures to polycyclic aromatic hydrocarbons. Toxicol Ind Health 6:209-223.
39. Millikan R, Pittman G, Tse CK, Savitz DA, Newman B, Bell D. 2000. Glutathione S-transferases M1, T1, and P1 and breast cancer. Cancer Epidemiol Biomarkers Prev 9(6):567-573.
40. Mitrunen K, Hirvonen A. 2003. Molecular epidemiology of sporadic breast cancer: the role of polymorphic genes involved in oestrogen biosynthesis and metabolism. Mutat Res 544:9-41.
41. Nakajima T, Elovaara E, Anttila S, Hirvonen A, Camus AM, Hayes JD, et al. 1995. Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer. Carcinogenesis 16(4):707-711.
42. NCBI (National Center for Biotechnology Information). 2009a. GenBank Overview. Available: http://www.ncbi.nlm.nih.gov/Genbank/ [accessed 10 March 2009].
43. NCBI (National Center for Biotechnology Information). 2009b. UniGene. Available: http://www.ncbi.nlm.nih.gov/unigene [accessed 10 March 2009].
44. Pavanello S, Clonfero E. 2000. Biological indicators of genotoxic risk and metabolic polymorphisms. Mutat Res 463:285-308.
45. Pelin K, Hirvonen A, Norppa H. 1996. Influence of erythrocyte glutathione-S transferase T1 on sister chromatid exchanges induced by diepoxybutane in cultured human lymphocytes. Mutagenesis 11:213-215.
46. Rothman KJ, Greenland S. 1998. Modern Epidemiology. Philadelphia:Lippincott-Raven Publishers.
47. Rothman N, Shields PG, Poirier MC, Harrington AM, Ford DP, Strickland PT. 1995. The impact of glutathione S-transferase M1 and cytochrome P450 1A1 genotypes on white-blood-cell polycyclic aromatic hydrocarbon-DNA adduct levels in humans. Mol Carcinog 14(1):63-68.
48. Rundle A, Tang D, Hibshoosh H, Estabrook A, Schnabel F, Cao W, et al. 2000a. The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer. Carcinogenesis 21:1281-1289.
49. Rundle A, Tang D, Mooney L, Grumet S, Perera F. 2003. The interaction between alcohol consumption and GSTM1 genotype on polycyclic aromatic hydrocarbon-DNA adduct levels in breast tissue. Cancer Epidemiol Biomarkers Prev 12(9):911-914.
50. Rundle A, Tang D, Zhou J, Cho S, Perera FP. 2000b. The association between glutathione S-transferase M1 genotype and polycyclic aromatic hydrocarbon-DNA adducts in breast tissue. Cancer Epidemiol Biomarkers Prev 9:1079-1085.
51. Ryberg D, Skaug V, Hewer A, Philips DH, Harries LW, Wolf CR, et al. 1997. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 18:1285-1289.
52. Shantakumar S, Gammon MD, Eng SM, Sagiv SK, Gaudet MM, Teitelbaum SL, et al. 2005. Residential environmental exposures and other characteristics associated with detectable PAH-DNA adducts in peripheral mononuclear cells in a population-based sample of adult females. J Expo Anal Environ Epidemiol 15(6):482-490.
53. Shimada T. 2006. Xenobiotic-metabolizing enzymes involved in the activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet 24:257-276.
54. Spurdle AB, Chang JH, Byrnes GB, Chen X, Dite GS, McCredie MR, et al. 2007. A systematic approach to analyzing gene-gene interactions: polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer risk. Cancer Epidemiol Biomarkers Prev 16(4):769-774.
55. Steck SE, Gammon MD, Hebert JR, Wall DE, Zeisel SH. 2007a. GSTM1, GSTT1, GSTP1, and GSTA1 polymorphisms and urinary isothiocyanate metabolites following broccoli consumption in humans. J Nutr 137(4):904-909.
56. Steck SE, Gaudet MM, Britton JA, Teitelbaum SL, Terry MB, Neugut AI, et al. 2007b. Interactions among GSTM1, GSTT1 and GSTP1 polymorphisms, cruciferous vegetable intake and breast cancer risk. Carcinogenesis 28(9):1954-1959.
57. Terry PD, Goodman M. 2006. Is the association between cigarette smoking and breast cancer modified by genotype? A review of epidemiologic studies and meta-analysis. Cancer Epidemiol Biomarkers Prev 15(4):602-611.
58. Upadhyaya P, Rao P, Hochalter JB, Li ZZ, Villalta PW, Hecht SS. 2006. Quantitation of N-acetyl-S-(9,10-dihydro-9-hydroxy-10-phenanthryl)-L-cysteine in human urine: comparison of glutathione-S-transferase genotypes in smokers. Chem Res Toxicol 19:1234-1240.
59. van der Hel OL, Bueno-de-Mesquita HB, van Gils CH, Roest M, Slothouber B, Grobbee DE, et al. 2005. Cumulative genetic defects in carcinogen metabolism may increase breast cancer risk (The Netherlands). Cancer Causes Control 16(6):675-681.
60. Vogl FD, Taioli E, Maugard C, Zheng W, Pinto LF, Ambrosone C, et al. 2004. Glutathione S-transferases M1, T1, and P1 and breast cancer: a pooled analysis. Cancer Epidemiol Biomarkers Prev 13(9):1473-1479.
61. Waldman JM, Lioy PJ, Greenberg A, Butler JP. 1991. Analysis of human exposure to benzo(a)pyrene via inhalation and food ingestion in the Total Human Environmental Exposure Study (THEES). J Expo Anal Environ Epidemiol 1:193-225.
62. Watson MA, Stewart RK, Smith GB, Massey TE, Bell DA. 1998. Human glutathione S-transferase P1 polymorphism: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 19:275-280.
63. Weiserbs KF, Jacobson JS, Begg MD, Wang LW, Wang Q, Agrawal M, et al. 2003. A cross-sectional study of polycyclic aromatic hydrocarbon-DNA adducts and polymorphism of glutathione S-transferases among heavy smokers by race/ethnicity. Biomarkers 8(2):142-155.
64. Wogan GM, Hecht SS, Felton JS, Conney AH, Loeb LA. 2004. Environmental and chemical carcinogenesis. Semin Cancer Biol 14:473-486.
65. Zheng W, Wen WQ, Gustafson DR, Gross M, Cerhan JR, Folsom AR. 2002. GSTM1 and GSTT1 polymorphisms and post-menopausal breast cancer risk. Breast Cancer Res Treat 74(1):9-16.